Dr Richard E Pieri, MD | |
12800 Edgemere Blvd, Suite A, El Paso, TX 79924-2671 | |
(915) 504-6939 | |
(915) 504-6937 |
Full Name | Dr Richard E Pieri |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 34 Years |
Location | 12800 Edgemere Blvd, El Paso, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760433924 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | P2341 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Hospitals Of Providence - East Campus | El paso, TX | Hospital |
Las Palmas Medical Center | El paso, TX | Hospital |
Entity Name | Infectious Disease Center Of El Paso Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699033662 PECOS PAC ID: 2264688662 Enrollment ID: O20120816000697 |
News Archive
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
Approximately one-quarter of inter-birth intervals in low- and middle-income countries are less than 24 months in length, exposing infants to risks of prematurity, low birthweight, and death. Increased evidence of these health risks has emerged in the past few decades and, after a period of neglect, interest in postpartum family planning has followed, supported by organizations like WHO and USAID.
METTLER TOLEDO is pleased to present "Getting Weighing Right: The Importance of Leveling". The article informs balance operators and quality managers about the difference a level balance can make in accuracy, especially during high-risk processes with tight tolerances.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard E Pieri, MD 12800 Edgemere Blvd, Suite A, El Paso, TX 79924-2671 Ph: (915) 504-6939 | Dr Richard E Pieri, MD 12800 Edgemere Blvd, Suite A, El Paso, TX 79924-2671 Ph: (915) 504-6939 |
News Archive
EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
Approximately one-quarter of inter-birth intervals in low- and middle-income countries are less than 24 months in length, exposing infants to risks of prematurity, low birthweight, and death. Increased evidence of these health risks has emerged in the past few decades and, after a period of neglect, interest in postpartum family planning has followed, supported by organizations like WHO and USAID.
METTLER TOLEDO is pleased to present "Getting Weighing Right: The Importance of Leveling". The article informs balance operators and quality managers about the difference a level balance can make in accuracy, especially during high-risk processes with tight tolerances.
› Verified 6 days ago
Sara Alhariri, Infectious Disease Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 912-215-8000 | |
Dr. Ney Mckinley Gore Iii, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 5005 N Piedras St, William Beaumont Army Medical Center, El Paso, TX 79920 Phone: 915-569-1382 Fax: 915-569-1233 | |
Armando D. Meza, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4801 Alberta Ave., 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6647 Fax: 915-545-9799 | |
Carlos E. Rodriguez Castro, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4800 Alberta Ave, El Paso, TX 79905 Phone: 915-545-6626 | |
Dr. Pratik Naik, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5005 N Piedras St, El Paso, TX 79920 Phone: 915-742-2180 Fax: 915-742-1919 | |
Alejandro Robles, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 4801 Alberta Ave, El Paso, TX 79905 Phone: 915-215-5200 Fax: 915-215-8640 | |
Dr. Rey Francisco Rosario, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 E Cliff Dr, Suite 3e, El Paso, TX 79902 Phone: 915-626-5548 Fax: 915-626-5411 |